Study: Gene-Eden-VIR is Antiviral; Results of a Post-Marketing Clinical Study on a Natural Remedy

Share Article

polyDNA is pleased to announce that a new study published on August 21, 2013 in the journal Pharmacology & Pharmacy reports the results of a post marketing clinical study, which “showed that the natural product Gene-Eden-VIR safely and effectively decreases symptoms in individuals infected with the HPV, HSV, EBV, HCMV, and HCV (1).”

Herpes treatment
We are very happy that we were both successful in developing a natural product, and in proving that it works through a clinical study that followed FDA guidelines. - Mike Evans, polyDNA

A new clinical study proves that Gene-Eden-VIR is a safe and effective antiviral treatment (1). The study was published in the peer reviewed, scientific journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs.

To be more specific, the clinical study showed that Gene-Eden-VIR “is a safe and effective treatment against the Human Papillomavirus (HPV), Herpes Simplex Virus (HSV), Epstein Barr Virus (EBV), Human Cytomegalovirus (HCMV), and Hepatitis C Virus (HCV) (1).”

This study is unique in the natural, dietary supplement market. Most sellers of dietary supplements do not conduct clinical studies to test the effectiveness of their products since “the law does not consider dietary supplements as drugs, and therefore, does not require the FDA to evaluate the effectiveness of these supplements (1).”

This is one of the first times that a paper was published in a peer reviewed journal reporting a clinical study on a proprietary, patent protected, natural formula.

Mike Evans of polyDNA said “We believe in natural products. There are many untapped opportunities in this field that deserve serious scientific research. We are very happy that we were both successful in developing a natural product, and in proving that it works through a clinical study that followed FDA guidelines. As our mission says, polyDNA aims to develop and sell natural products that are as safe and effective as drugs.”

To view the entire paper, visit: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

We invite the media to contact us for interviews at: info(at)buy-gene-eden(dot)com or phone 585-250-9999.

###

References:

(1)    http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mike Davis
PolyDNA
+1 (585) 250-9999
Email >
Visit website